Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma

Cancer Letters

Volumn 297, Issue 1, 2010, Pages 84-90

  Jang, Su Jin ^a,b   Kang, Joo Hyun ^a   Kim, Kwang Il ^a   Lee, Tae Sup ^a   Lee, Yong Jin ^a   Lee, Kyo Chul ^a   Woo, Kwang Sun ^a   Chung, Wee Sup ^a   Kwon, Hee Chung ^a   Ryu, Chun Jeih ^b   Choi, Tae Hyun ^a   Choi, Chang Woon ^a   Lim, Sang Moo ^a   Cheon, Gi Jeong ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Sejong University   (South Korea)

Author keywords

Glioma; HSV1 tk; Luciferase; Molecular imaging; Suicidal gene therapy

Indexed keywords

5 (2 IODOVINYL) 2' DEOXYURIDINE; 9 [4 FLUORO 3 (HYDROMMETHYL)BUTYL]GUANINE; FIREFLY LUCIFERASE; FLUORINE 18; GANCICLOVIR; GUANINE DERIVATIVE; IODINE 125; LENTIVIRUS VECTOR; THYMIDINE KINASE; UNCLASSIFIED DRUG; 5-(2-IODOVINYL)-2'-DEOXYURIDINE; ANTINEOPLASTIC AGENT; HYBRID PROTEIN; IDOXURIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CANCER GENE THERAPY; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GLIOMA; HERPES SIMPLEX VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR VOLUME; TUMOR XENOGRAFT; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BRAIN NEOPLASMS; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; GENE THERAPY; GENE VECTOR; GENETICS; GLIOBLASTOMA; KINETICS; LENTIVIRINAE; LUMINESCENCE; METABOLISM; NUDE MOUSE; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; REPORTER GENE; SUICIDE TRANSGENE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GANCICLOVIR; GENE THERAPY; GENES, REPORTER; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; GLIOBLASTOMA; HERPESVIRUS 1, HUMAN; IDOXURIDINE; KINETICS; LENTIVIRUS; LUCIFERASES, FIREFLY; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED BALB C; MICE, NUDE; POSITRON-EMISSION TOMOGRAPHY; RATS; RECOMBINANT FUSION PROTEINS; THYMIDINE KINASE; TUMOR BURDEN; GENETIC THERAPY;

MUS; SIMPLEXVIRUS;

EID: 77956229309     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.04.028     Document Type: Article

References (32)

1. Springer C.J., Niculescu-Duvaz I. Prodrug-activating systems in suicide gene therapy. J. Clin. Invest. 2000, 105:1161-1167.
2. Yazawa K., Fisher W.E., Brunicardi F.C. Current progress in suicide gene therapy for cancer. World J. Surg. 2002, 26:783-789.
3. Bansal K., Engelhard H.H. Gene therapy for brain tumors. Curr. Oncol. Rep. 2000, 2:463-472.
4. Anderson W.F. Gene therapy scores against cancer. Nat. Med. 2000, 6:862-863.
5. Fillat C., Carrió M., Cascante A., Sangro B. Suicide gene therapy mediated by herpes simplex virus thymidine kinase gene/ganciclovir system: 15 years of application. Curr. Gene Ther. 2003, 3:13-26.
6. De Clercq E. Guanosine analogues as anti-herpesvirus agents. Nucleos. Nucleot. Nucl. Acids 2001, 19:1531-1541.
7. De Clercq E., Andrei G., Snoeck R., De Bolle, Naesens L., Degrève B., Balzarini J., Zhang Y., Schols D., Leyssen P., Ying C., Neyts J. Acyclic/carbicyclic guanosine analogues as anti-herpesvirus agents. Nucleos. Nucleot. Nucl. Acids 2001, 20:271-285.
8. Freeman S.M., Abboud C.N., Whartenby K.A., Packman C.H., Koeplin D.S., Moolten F.L., Abraham G.N. The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 1993, 53:5274-5283.
9. Mesnil M., Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 2000, 60:3989-3999.
10. Gambhir S.S., Herschman H.R., Cherry S.R., Barrio J.R., Satyamurthy N., Toyokuni T., Phelps M.E., Larson S.M., Balatoni J., Finn R., Sadelain M., Tjuvajev J., Blasberg R. Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2000, 2:118-138.
11. Serganova I., Blasberg R. Reporter gene imaging: potential impact on therapy. Nucl. Med. Biol. 2005, 32:763-780.
12. Kang J.H., Chung J.K. Molecular-genetic imaging based on reporter gene expression. J. Nucl. Med. 2008, 49:164S-179S.
13. Massoud T.F., Gambhir S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003, 17:545-580.
14. Iyer M., Sato M., Johnson M., Gambhir S.S., Wu L. Applications of molecular imaging in cancer therapy. Curr. Gene Ther. 2005, 59:607-618.
15. Tjuvajev J.G., Doubrovin M., Akhurst T., Cai S., Balatoni J., Alauddin M.M., Finn R., Bornmann W., Thaler H., Conti P.S., Blasberg R.G. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J. Nucl. Med. 2002, 43:1072-1083.
16. Gambhir S.S., Barrio J.R., Wu L., Iyer M., Namvari M., Satyamurthy N., Bauer E., Parrish C., MacLaren D.C., Borghei A.R., Green L.A., Sharfstein S., Berk A.J., Cherry S.R., Phelps M.E., Herschman H.R. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J. Nucl. Med. 1998, 39:2003-2011.
17. 3H]PCV for monitoring reporter gene expression of wild type and mutant herpes simplex virus type 1 thymidine kinase in cell culture. Mol. Imag. Biol. 2005, 7:296-303.
18. 14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs. stable transfection. Eur. J. Nucl. Med. Mol. Imag. 2003, 30:1547-1560.
19. Perry J.R., DeAngelis L.M., Schold S.C., Burger P.C., Brem H., Brown M.T., Curran W.J., Scott C.B., Prados M.D., Kaplan R., Cairncross J.G. Challenges in the design and conduct of phase III brain tumor therapy trials. Neurology 1997, 49:912-917.
20. Culver K.W., Ram Z., Walbridge S., Ishii H., Oldfield E.H., Blaese R.M. In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science 1992, 256:1550-1552.
21. Vincent A.J.P.E., Vogels R., Van Someren G., Esandi M.C., Noteboom J.L., Avezaat C.J.J., Vecht C., Van Bekkum D.W., Valerio D., Bout A., Hoogerbrugge P.M. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors. Human Gene Ther. 1996, 7:197-205.
22. Okada H., Miyamura K., Itoh T., Hagiwara M., Wakabayashi T., Mizuno M., Colosi P., Kurtzman G., Yoshida J. Gene therapy against an experimental glioma using adeno-associated virus vectors. Gene Ther. 1996, 3:957-964.
23. Kramm C.M., Chase M., Herrlinger U., Jacobs A., Pechan P.A., Rainov N.G., Sena-Esteves M., Aghi M., Barnett F.H., Chiocca E.A., Breakefield X.O. Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. Human Gene Ther. 1997, 8:2057-2068.
24. Trask T.W., Trask R.P., Aguilar-Cordova E., Shine H.D., Wyde P.R., Goodman J.C., Hamilton W.J., Rojas-Martinez A., Chen S.H., Woo S.L., Grossman R.G. Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol. Ther. 2000, 1:195-203.
25. Engelhard H.H. Gene therapy for brain tumors: the fundamentals. Surg. Neurol. 2000, 54:3-9.
26. Contag C.H., Jenkins D., Contag P.R., Negrin R.S. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2000, 2:41-52.
27. Wu J.C., Sundaresan G., Iyer M., Gambhir S.S. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol. Ther. 2001, 4:297-306.
28. Shin J.H., Chung J.K., Kang J.H., Lee Y.J., Kim K.I., So Y., Jeong J.M., Lee D.S., Lee M.C. Non-invasive imaging for monitoring of viable cancer cells using dual-imaging reporter gene. J. Nucl. Med. 2004, 45:2109-2115.
29. Soling A., Theiss C., Jungmichel S., Rainov N.G. A dual function fusion protein of herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma. Genet. Vaccines Ther. 2004, 2:7.
30. Jacobs A., Voges J., Reszka R., Lercher M., Gossmann A., Kracht L., Kaestle C., Wagner R., Wienhard K., Heiss W.D. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 2001, 9283:727-729.
31. Ponomarev V., Doubrovin M., Serganova I., Vider J., Shavrin A., Beresten T., Ivanova A., Ageyeva L., Tourkova V., Balatoni J., Bornmann W., Blasberg R., Tjuvajev J.G. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur. J. Nucl. Med. Mol. Imag. 2004, 31:740-751.
32. Ray P., De A., Min J.J., Tsien R.Y., Gambhir S.S. Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res. 2004, 64:1323-1330.